돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2090805생성일: 2026년 10월 27일

1-(1-Methyl-4-piperidinyl)piperazine → 2-[1-(4-Methoxy-2,6-dimethyl-phenylsulfonyl)-piperidin-2-ylmethoxy]-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-ethanone

https://huagongshe.com/reaction/2090805

반응식

참여 물질

역할이름HCID투입량
반응물1-(1-Methyl-4-piperidinyl)piperazineHCID 566324—
반응물2-((1-(4-Methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)methoxy)acetic acidHCID 57436800—
용매DichloromethaneHCID 6344—
생성물2-[1-(4-Methoxy-2,6-dimethyl-phenylsulfonyl)-piperidin-2-ylmethoxy]-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-ethanoneHCID 24945574—

반응 단계

N,N′-Carbonyldiimidazole (114 mg, 0.706 mmol) was added to a solution of 2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)methoxy)acetic acid (250 mg, 0.673 mmol) in dichloromethane (15 ml), and the mixture was stirred for 1 h at room temperature. A solution of 1-(1-methylpiperidin-4-yl)piperazine (123 mg, 0.673 mmol) in dichloromethane (5 ml) was then added, and the reaction mixture was stirred for 15 h at room temperature. The reaction mixture was then extracted with water (20 ml) and saturated sodium chloride solution (20 ml), and the organic phase was dried over magnesium sulfate and concentrated in vacuo. The crude product was purified by flash chromatography using dichloromethane/methanol (97:3→90:10).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08435978B2
출처 데이터셋uspto-grants-2013_05
ORD IDord-6601b9ab513848f6b96a0bce5eed963b
출처 메모uspto-grants-2013_05